Advances in quantifying apolipoproteins using LC-MS/MS technology: implications for the clinic

References

• Lassman ME, McLaughlin TM, Zhou H, et al. Simultaneous quantitation and size characterization of apolipoprotein(a) by ultra-performance liquid chromatography/mass spectrometry. Rapid Commun Mass Spectrom. 2014;28:1101–1106.
   PubMed Web of Science ®Google Scholar
• Rezeli M, Vegvari A, Fehniger TE, et al. Moving towards high density clinical signature studies with a human proteome catalogue developing multiplexing mass spectrometry assay panels. J Clin Bioinforma. 2011;1:7.
   PubMedGoogle Scholar
• Marks V, Cantor T, Mesko D, et al. Differential diagnosis by laboratory medicine. A Quick Ref Physicians. 2002;107. ISBN: 978-3-642-62765-1.
   Google Scholar
• Dominiczak MH, Caslake MJ. Apolipoproteins: metabolic role and clinical biochemistry applications. Ann Clin Biochem. 2011;48:498–515.
   PubMed Web of Science ®Google Scholar
• Sniderman AD, Marcovina SM. Apolipoprotein A1 and B. Clin Lab Med. 2006;26:733–750.
   PubMed Web of Science ®Google Scholar
• Walldius G, Jungner I. 2006. The apoB/apoA-I ratio: a strong, new risk factor for cardiovascular disease and a target for lipid-lowering therapy–a review of the evidence. 259:493–519.
   Google Scholar
• Walldius G, Jungner I, Aastveit AH, et al. The apoB/apoA-I ratio is better than the cholesterol ratios to estimate the balance between plasma proatherogenic and antiatherogenic lipoproteins and to predict coronary risk. Clin Chem Lab Med. 2004;42:1355–1363.
   PubMed Web of Science ®Google Scholar
• Langlois MR, Descamps OS, Van Der Laarse A, et al. Clinical impact of direct HDLc and LDLc method bias in hypertriglyceridemia. A simulation study of the EAS-EFLM Collaborative Project Group. Atherosclerosis. 2014;233:83–90.
   PubMed Web of Science ®Google Scholar
• Miller WG, Myers GL, Sakurabayashi I, et al. Seven direct methods for measuring HDL and LDL cholesterol compared with ultracentrifugation reference measurement procedures. Clin Chem. 2010;56:977–986.
   PubMed Web of Science ®Google Scholar
• Marcovina SM, Albers JJ, Henderson LO, et al. International federation of clinical chemistry standardization project for measurements of apolipoproteins A-I and B. III. Comparability of apolipoprotein A-I values by use of international reference material. Clin Chem. 1993;39:773–781.
   PubMed Web of Science ®Google Scholar
• Marcovina S, Packard CJ. Measurement and meaning of apolipoprotein AI and apolipoprotein B plasma levels. J Intern Med. 2006;259:437–446.
   PubMed Web of Science ®Google Scholar
• Marcovina, SM, Albers JJ, Kennedy H, et al. International Federation of Clinical Chemistry standardization project for measurements of apolipoproteins A-I and B. IV. Comparability of apolipoprotein B values by use of International Reference Material. Clin Chem. 1994;40:586–592.
   PubMed Web of Science ®Google Scholar
• Rifai N, Warnick GR, McNamara JR, et al. Measurement of low-density-lipoprotein cholesterol in serum: a status report. Clin Chem. 1992;38:150–160.
   PubMed Web of Science ®Google Scholar
• Pan Y, Zhou H, Mahsut A, et al. Static and turnover kinetic measurement of protein biomarkers involved in triglyceride metabolism including apoB48 and apoA5 by LC/MS/MS. J Lipid Res. 2014;55:1179–1187.
   PubMed Web of Science ®Google Scholar
• van den Broek I, Romijn FPHTM, Nouta J, et al. Automated multiplex LC-MS/MS Assay for Quantifying Serum Apolipoproteins A-I, B, C-I, C-II, C-III, and E with Qualitative Apolipoprotein E Phenotyping. Clin Chem. 2016;62:188–197.
   PubMed Web of Science ®Google Scholar
• Wildsmith KR, Han B, Bateman RJ. Method for the simultaneous quantitation of apolipoprotein E isoforms using tandem mass spectrometry. Anal Biochem. 2009;395:116–118.
   PubMed Web of Science ®Google Scholar
• Hoofnagle AN, Wener MH. The fundamental flaws of immunoassays and potential solutions using tandem mass spectrometry. J Immunol Methods. 2009;347:3–11.
   PubMed Web of Science ®Google Scholar
• Ceglarek U, Dittrich J, Becker S, et al. Quantification of seven apolipoproteins in human plasma by proteotypic peptides using fast LC-MS/MS. Proteomics Clin Appl. 2013;7:794–801.
   PubMed Web of Science ®Google Scholar
• Hoofnagle AN, Becker JO, Oda MN, et al. Multiple-reaction monitoring-mass spectrometric assays can accurately measure the relative protein abundance in complex mixtures. Clin Chem. 2012;58:777–781.
   PubMed Web of Science ®Google Scholar
• Lassman ME, McLaughlin TM, Somers EP, et al. A rapid method for cross-species quantitation of apolipoproteins A1, B48 and B100 in plasma by ultra-performance liquid chromatography/tandem mass spectrometry. Rapid Commun Mass Spectrom. 2012;26:101–108.
   PubMed Web of Science ®Google Scholar
• Parks BA, Schieltz DM, Andrews ML, et al. High throughput quantification of apolipoproteins A-I and B-100 by Isotope dilution mass spectrometry targeting fast trypsin releasable peptides without reduction and alkylation. Proteomics Clin Appl. 2017;11:1600128.
   PubMed Web of Science ®Google Scholar
• Razavi M, Anderson NL, Yip R, et al. Multiplexed longitudinal measurement of protein biomarkers in DBS using an automated SISCAPA workflow. Bioanalysis. 2016;8:1597–1609.
   PubMed Web of Science ®Google Scholar
• Shah V, Lassman ME, Chen Y, et al. Achieving efficient digestion faster with Flash Digest: potential alternative to multi-step detergent assisted in-solution digestion in quantitative proteomics experiments. Rapid Commun Mass Spectrom. 2017;31(2):193-199.
   PubMed Web of Science ®Google Scholar
• Smit NP, Romijn FPHTM, van den Broek I, et al. Metrological traceability in mass spectrometry-based targeted protein quantitation: a proof-of-principle study for serum apolipoproteins A-I and B100. J Proteomics. 2014;109:143–161.
   PubMed Web of Science ®Google Scholar
• Toth CA, Kuklenyik Z, Jones JI, et al. On-column trypsin digestion coupled with LC-MS/MS for quantification of apolipoproteins. J Proteomics. 2016;150:258–267.
   PubMed Web of Science ®Google Scholar
• Trenchevska O, Schaab MR, Nelson RW, et al. Development of multiplex mass spectrometric immunoassay for detection and quantification of apolipoproteins C-I, C-II, C-III and their proteoforms. Methods. 2015;81:86–92.
   PubMed Web of Science ®Google Scholar
• van den Broek I, Fu Q, Kushon S, et al. Application of volumetric absorptive microsampling for robust, high-throughput mass spectrometric quantification of circulating protein biomarkers, Clinical Mass Spectrometry. 2017. doi: http://dx.doi.org/10.1016/j.clinms.2017.08.004.
   Google Scholar
• van den Broek I, Nouta J, Razavi M, et al. Quantification of serum apolipoproteins A-I and B-100 in clinical samples using an automated SISCAPA-MALDI-TOF-MS workflow. Methods. 2015;81:74–85.
   PubMed Web of Science ®Google Scholar
• Barr JR, Maggio VL, Patterson DG, et al. Isotope dilution–mass spectrometric quantification of specific proteins: model application with apolipoprotein A-I. Clin Chem. 1996;42:1676–1682.
   PubMed Web of Science ®Google Scholar
• Agger SA, Marney LC, Hoofnagle AN. Simultaneous quantification of apolipoprotein A-I and apolipoprotein B by liquid-chromatography-multiple- reaction-monitoring mass spectrometry. Clin Chem. 2010;56:1804–1813.
   PubMed Web of Science ®Google Scholar
• Kay RG, Gregory B, Grace PB, et al. The application of ultra-performance liquid chromatography/tandem mass spectrometry to the detection and quantitation of apolipoproteins in human serum. Rapid Commun Mass Spectrom. 2007;21:2585–2593.
   PubMed Web of Science ®Google Scholar
• Vandermarliere E, Mueller M, Martens L. Getting intimate with trypsin, the leading protease in proteomics. Mass Spectrom Rev. 2013;32:453–465.
   PubMed Web of Science ®Google Scholar
• van den Broek I, Niessen WM, van Dongen WD. Bioanalytical LC-MS/MS of protein-based biopharmaceuticals. J Chromatogr B Analyt Technol Biomed Life Sci. 2013;929:161–179.
   PubMed Web of Science ®Google Scholar
• Hirtz C, Vialaret J, Nouadje G, et al. Development of new quantitative mass spectrometry and semi-automatic isofocusing methods for the determination of Apolipoprotein E typing. Clin Chim Acta. 2016;454:33–38.
   PubMed Web of Science ®Google Scholar
• Zhou H, Hoek M, Yi P, et al. Rapid detection and quantification of apolipoprotein L1 genetic variants and total levels in plasma by ultra-performance liquid chromatography/tandem mass spectrometry. Rapid Commun Mass Spectrom. 2013;27:2639–2647.
   PubMed Web of Science ®Google Scholar
• van den Broek I, Romijn FPHTM, Smit NPM, et al. Quantifying protein measurands by peptide measurements: where do errors arise? J Proteome Res. 2015;14:928–942.
   PubMed Web of Science ®Google Scholar
• Bollinger JG, Stergachis AB, Johnson RS, et al. Selecting optimal peptides for targeted proteomic experiments in human plasma using in vitro synthesized proteins as analytical standards. Methods Mol Biol. 2016;1410:207–221.
   PubMedGoogle Scholar
• Fu Q, Grote E, Zhu J, et al. An empirical approach to signature peptide choice for selected reaction monitoring: quantification of Uromodulin in Urine. Clin Chem. 2016;62:198–207.
   PubMed Web of Science ®Google Scholar
• Gafvels M, Bengtson P. A fast semi-quantitative LC-MS method for measurement of intact apolipoprotein A-I reveals novel proteoforms in serum. Clin Chim Acta. 2015;442:87–95.
   PubMed Web of Science ®Google Scholar
• Proc JL, Kuzyk MA, Hardie DB, et al. A quantitative study of the effects of chaotropic agents, surfactants, and solvents on the digestion efficiency of human plasma proteins by trypsin. J Proteome Res. 2010;9:5422–5437.
   PubMed Web of Science ®Google Scholar
• Anderson NL, Anderson NG, Haines LR, et al. Mass spectrometric quantitation of peptides and proteins using Stable Isotope Standards and Capture by Anti-Peptide Antibodies (SISCAPA). J Proteome Res. 2004;3:235–244.
   PubMed Web of Science ®Google Scholar
• Domanski D, Percy AJ, Yang J, et al. MRM-based multiplexed quantitation of 67 putative cardiovascular disease biomarkers in human plasma. Proteomics. 2012;12:1222–1243.
   PubMed Web of Science ®Google Scholar
• Kuzyk MA, Smith D, Yang J, et al. Multiple reaction monitoring-based, multiplexed, absolute quantitation of 45 proteins in human plasma. Mol Cell Proteomics. 2009;8:1860–1877.
   PubMed Web of Science ®Google Scholar
• van den Broek I, Van Dongen WD. LC-MS-based quantification of intact proteins: perspective for clinical and bioanalytical applications. Bioanalysis. 2015;7:1943–1958.
   PubMed Web of Science ®Google Scholar
• Hoofnagle AN, Whiteaker JR, Carr SA, et al. Recommendations for the generation, quantification, storage, and handling of peptides used for mass spectrometry-based assays. Clin Chem. 2016;62:48–69.
   PubMed Web of Science ®Google Scholar
• Shuford CM, Sederoff RR, Chiang VL, et al. Peptide production and decay rates affect the quantitative accuracy of protein cleavage isotope dilution mass spectrometry (PC-IDMS). Mol Cell Proteomics. 2012;11:814–823.
   PubMed Web of Science ®Google Scholar
• Carr SA, Abbatiello SE, Ackermann BL, et al. Targeted peptide measurements in biology and medicine: best practices for mass spectrometry-based assay development using a fit-for-purpose approach. Mol Cell Proteomics. 2014;13:907–917.
   PubMed Web of Science ®Google Scholar
• Millan J, Pintó X, Muñoz A, et al. Lipoprotein ratios: physiological significance and clinical usefulness in cardiovascular prevention. Vasc Health Risk Manag. 2009;5:757–765.
   PubMedGoogle Scholar
• Walldius G, Jungner I, Holme I, et al. High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study. Lancet. 2001;358:2026–2033.
   PubMed Web of Science ®Google Scholar
• McQueen MJ, Hawken S, Wang X, et al. Lipids, lipoproteins, and apolipoproteins as risk markers of myocardial infarction in 52 countries (the INTERHEART study): a case-control study. Lancet. 2008;372:224–233.
   PubMed Web of Science ®Google Scholar
• Lamarche B, Moorjani S, Lupien PJ, et al. Apolipoprotein A-I and B levels and the risk of ischemic heart disease during a five-year follow-up of men in the Quebec cardiovascular study. Circulation. 1996;94:273–278.
   PubMed Web of Science ®Google Scholar
• Canoui-Poitrine F, Luc G, Bard J-M, et al. Relative contribution of lipids and apolipoproteins to incident coronary heart disease and ischemic stroke: the PRIME Study. Cerebrovasc Dis. 2010;30:252–259.
   PubMed Web of Science ®Google Scholar
• Sharrett AR, Ballantyne CM, Coady SA, et al. Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a), apolipoproteins A-I and B, and HDL density subfractions: the Atherosclerosis Risk in Communities (ARIC) Study. Circulation. 2001;104:1108–1113.
   PubMed Web of Science ®Google Scholar
• Jong MC, Hofker MH, Havekes LM. Role of ApoCs in lipoprotein metabolism: functional differences between ApoC1, ApoC2, and ApoC3. Arterioscler Thromb Vasc Biol. 1999;19:472–484.
   PubMed Web of Science ®Google Scholar
• Koska J, Yassine H, Trenchevska O, et al. Disialylated apolipoprotein C-III proteoform is associated with improved lipids in prediabetes and type 2 diabetes. J Lipid Res. 2016;57:894–905.
   PubMed Web of Science ®Google Scholar
• Phillips MC. Apolipoprotein E isoforms and lipoprotein metabolism. IUBMB Life. 2014;66:616–623.
   PubMed Web of Science ®Google Scholar
• Pechlaner R, Tsimikas S, Yin X, et al. Very-low-density lipoprotein-associated apolipoproteins predict cardiovascular events and are lowered by inhibition of APOC-III. J Am Coll Cardiol. 2017;69:789–800.
   PubMed Web of Science ®Google Scholar
• Tailleux A, Duriez P, Fruchart JC, et al. Apolipoprotein A-II, HDL metabolism and atherosclerosis. Atherosclerosis. 2002;164:1–13.
   PubMed Web of Science ®Google Scholar
• Wang F, Kohan AB, Lo C-M, et al. Apolipoprotein A-IV: a protein intimately involved in metabolism. J Lipid Res. 2015;56:1403–1418.
   PubMed Web of Science ®Google Scholar
• Huang Y. Mechanisms linking apolipoprotein E isoforms with cardiovascular and neurological diseases. Curr Opin Lipidol. 2010;21:337–345.
   PubMed Web of Science ®Google Scholar
• Genovese G, Friedman DJ, Ross MD, et al. Association of trypanolytic ApoL1 variants with kidney disease in African Americans. Science. 2010;329:841–845.
   PubMed Web of Science ®Google Scholar
• Chambers AG, Percy AJ, Yang J, et al. multiple reaction monitoring enables precise quantification of 97 proteins in dried blood spots. Mol Cell Proteomics. 2015;14:3094–3104.
   PubMed Web of Science ®Google Scholar
• Chambers AG, Percy AJ, Yang J, et al. Multiplexed quantitation of endogenous proteins in dried blood spots by multiple reaction monitoring-mass spectrometry. Mol Cell Proteomics. 2013;12:781–791.
   PubMed Web of Science ®Google Scholar
• Henderson CM, Bollinger JG, Becker JO, et al. Quantification by nano liquid chromatography parallel reaction monitoring mass spectrometry of human apolipoprotein A-I, apolipoprotein B, and hemoglobin A1c in dried blood spots. Proteomics Clin Appl. 2017;11:1600103.
   PubMed Web of Science ®Google Scholar
• Denniff P, Spooner N. Volumetric absorptive microsampling: a dried sample collection technique for quantitative bioanalysis. Anal Chem. 2014;86:8489–8495.
   PubMed Web of Science ®Google Scholar
• Chan DC, Chen MM, Ooi EM, et al. An ABC of apolipoprotein C-III: a clinically useful new cardiovascular risk factor? Int J Clin Pract. 2008;62:799–809.
   PubMed Web of Science ®Google Scholar
• Tighe PJ, Ryder RR, Todd I, et al. ELISA in the multiplex era: potentials and pitfalls. Proteomics Clin Appl. 2015;9:406–422.
   PubMed Web of Science ®Google Scholar